• 8 Hits
  • Search Condition : Filter (MeSH = Non-alcoholic Fatty Liver Disease* / metabolism)
Species Resource Title
Human and Animal Cells Hep G2(RCB1886) The Beneficial Effect of Brazilian Propolis for Liver Damage through Endoplasmic Reticulum Stress.
Human and Animal Cells RAW 264(RCB0535) , Hep G2(RCB1886) Carbon monoxide-loaded red blood cells ameliorate metabolic dysfunction-associated steatohepatitis progression via enhancing AMP-activated protein kinase activity and inhibiting Kupffer cell activation.
DNA material CSII-EF-IRES2-Venus (RDB04384) , CSII-EF-MCS (RDB04378) , pCMV-VSVG-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) miR-27b targets MAIP1 to mediate lipid accumulation in cultured human and mouse hepatic cells.
Mice RBRC02975 Liver lipophagy ameliorates nonalcoholic steatohepatitis through extracellular lipid secretion.
Mice , DNA material RBRC01834 , CSII-CMV-MCS (RDB04377) , pCMV-VSV-G-RSV-Rev (RDB04393) , pCAG-HIVgp (RDB04394) FOXK1 promotes nonalcoholic fatty liver disease by mediating mTORC1-dependent inhibition of hepatic fatty acid oxidation.
Medaka d-rR/TOKYO (MT837) Effects of a selective PPARα modulator, sodium-glucose cotransporter 2 inhibitor, and statin on the myocardial morphology of medaka nonalcoholic fatty liver disease model.
Human and Animal Cells CACO-2(RCB0988) Rifaximin and lubiprostone mitigate liver fibrosis development by repairing gut barrier function in diet-induced rat steatohepatitis.
Mice RBRC02388 MD2 deficiency prevents high-fat diet-induced AMPK suppression and lipid accumulation through regulating TBK1 in non-alcoholic fatty liver disease.